Traditional Chinese medicine composition for inhibiting malignant tumors
A malignant tumor and composition technology, which is applied in the direction of drug combination, antineoplastic drugs, and pharmaceutical formulations, can solve problems such as lack of experience and achievements in promotion and use, inability to completely cure tumors, and increase patient suffering, so as to achieve good therapeutic effects. Reliable curative effect, inhibition and reduction of tumor effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0043] The traditional Chinese medicine composition for inhibiting malignant tumors of the present invention, its raw material composition according to the mass ratio is: 15 parts of green beans; 2 parts of Coptidis; 9 parts of Scrophulariaceae; 5 parts of leaves; 5 parts of leaking reed; 5 parts of mountain bean root; 5 parts of asparagus; share.
Embodiment 2
[0045] The traditional Chinese medicine composition for inhibiting malignant tumors of the present invention has the following raw materials according to the mass ratio: 25 parts of green bean; 3 parts of coptis; 11 parts of Scrophulariaceae; 8 parts of black medicine; 8 parts of leaves; 8 parts of leaking reed; 7 parts of mountain bean root; 12 parts of asparagus; 8 parts of bitter almond; share.
Embodiment 3
[0047] The traditional Chinese medicine composition for inhibiting malignant tumors of the present invention, its raw material composition according to the mass ratio is: 30 parts of green bean; 5 parts of berberine; 12 parts of Scrophulariaceae; 10 parts of leaves; 10 parts of leaking reed; 8 parts of mountain bean root; 15 parts of asparagus; 10 parts of bitter almond; 10 parts of earthworm; share.
[0048] Examples of medical cases:
[0049] Randomly select 76 patients with advanced gastric cancer, 57 patients with advanced colon cancer, and 78 patients with advanced lung cancer. After negotiating with patients and their families and signing informed consent, clinical treatment trials will be conducted. The above patients were randomly divided into three groups. The first group was surgical treatment group, which adopted surgical treatment plus supportive treatment; the second group was western medicine chemotherapy group, which adopted drug chemotherapy plus supportive tr...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com